BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24530255)

  • 1. Malakoplakia in a patient with complicated urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lee WS; Chen WY; Ou TY; Chen FL; Lin YW
    J Microbiol Immunol Infect; 2015 Jun; 48(3):345-6. PubMed ID: 24530255
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiresistant extended-spectrum β-lactamase producing Escherichia coli in human urine samples in Portugal.
    Pacheco R; Correia S; Monteiro R; Gonçalves A; Radhouani H; Ramos S; Carvalho E; Carvalho J; Igrejas G; Poeta P
    J Microbiol Immunol Infect; 2013 Oct; 46(5):399-404. PubMed ID: 22727541
    [No Abstract]   [Full Text] [Related]  

  • 3. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection.
    Tasbakan MI; Pullukcu H; Sipahi OR; Yamazhan T; Ulusoy S
    Int J Antimicrob Agents; 2012 Dec; 40(6):554-6. PubMed ID: 23063743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Ena J; Arjona F; Martínez-Peinado C; López-Perezagua Mdel M; Amador C
    Urology; 2006 Dec; 68(6):1169-74. PubMed ID: 17169640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
    Bi W; Li B; Song J; Hong Y; Zhang X; Liu H; Lu H; Zhou T; Cao J
    Int J Antimicrob Agents; 2017 Jul; 50(1):29-34. PubMed ID: 28456703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First detection of VIM-4 metallo-β-lactamase-producing Escherichia coli in Russia.
    Shevchenko OV; Mudrak DY; Skleenova EY; Kozyreva VK; Ilina EN; Ikryannikova LN; Alexandrova IA; Sidorenko SV; Edelstein MV
    Clin Microbiol Infect; 2012 Jul; 18(7):E214-7. PubMed ID: 22487052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin and co-trimoxazole resistance and extended spectrum beta-lactamase production in Escherichia coli strains isolated from urinary tract infections.
    Ozden M; Kalkan A; Demirdag K; Kilic SS; Ozdarendeli A
    Int J Antimicrob Agents; 2003 May; 21(5):492-3. PubMed ID: 12727086
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract]   [Full Text] [Related]  

  • 10. [Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
    Rodríguez-Avial C; Rodríguez-Avial I; Hernández E; Picazo JJ
    Rev Esp Quimioter; 2013 Mar; 26(1):43-6. PubMed ID: 23546462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of multiresistance and extended-spectrum beta-lactamases amongst urinary Escherichia coli in Oxford, UK.
    Wyllie DH; Baxter E; Morgan M; Bowler IC
    J Antimicrob Chemother; 2005 Nov; 56(5):986-8. PubMed ID: 16183665
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent extended-spectrum beta-lactamase urinary tract infection.
    DeBusscher J; Zhang L; Buxton M; Foxman B; Barbosa-Cesnik C
    Emerg Infect Dis; 2009 Nov; 15(11):1862-4. PubMed ID: 19891891
    [No Abstract]   [Full Text] [Related]  

  • 14. Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.
    Madigan T; Johnson JR; Clabots C; Johnston BD; Porter SB; Slater BS; Banerjee R
    Clin Infect Dis; 2015 Jul; 61(1):e5-12. PubMed ID: 25828998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosfomycin susceptibility among extended-spectrum-beta-lactamase-producing Escherichia coli in Nottingham, UK.
    Chislett RJ; White G; Hills T; Turner DP
    J Antimicrob Chemother; 2010 May; 65(5):1076-7. PubMed ID: 20181572
    [No Abstract]   [Full Text] [Related]  

  • 16. Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil.
    Gonçalves LF; de Oliveira Martins-Júnior P; de Melo ABF; da Silva RCRM; de Paulo Martins V; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2016 Sep; 6():1-4. PubMed ID: 27530830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of extended-spectrum β-lactamase-producing Escherichia coli in catheter-associated urinary tract infection in neurogenic bladder patients.
    Takaba K; Shigemura K; Osawa K; Nomi M; Fujisawa M; Arakawa S
    Am J Infect Control; 2014 Mar; 42(3):e29-31. PubMed ID: 24581025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urine of nonhospitalized patients in the Zagreb region].
    Marijan T; Plecko V; Vranes J; Dzepina AM; Bedenić B; Kalenić S
    Med Glas (Zenica); 2010 Feb; 7(1):46-53. PubMed ID: 20387724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
    You JH; Kei HW; Lau WC; Wong KY; Marasinghe T; Lee N; Ip M
    J Hosp Infect; 2008 Feb; 68(2):181-3. PubMed ID: 18194826
    [No Abstract]   [Full Text] [Related]  

  • 20. Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Cho SY; Choi SM; Park SH; Lee DG; Choi JH; Yoo JH
    Korean J Intern Med; 2016 Jan; 31(1):156-61. PubMed ID: 26767869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.